ما هو glp 1 أدوية GLP‑1: مكافحة السمنة وعلاج السكري ما هو الببتيد الشبيه بالجلوكاجون

10

Current law prohibits Medicare from covering obesity drugs and gives states flexibility to cover weight loss drugs under Medicaid Limitations on coverage for obesity drugs in Medicare and Medicaid mean that millions of people who have obesity and might benefit from taking GLP-1s may be unable to access them unless they are able to pay the full cash price out of their own pockets, which would likely be prohibitive for people with Medicaid who must have low incomes to qualify for the program, as well as for many people on Medicare with low and modest incomes

doi: 10.1080/0886022X.2025.2517402 169

Diabetologia 63 (2), 221228

Ask us a question Not sure if you are ready for an appointment